Wall Street welcomed three life science companies to the public markets this week. 10x Genomics led the way Wednesday, followed by SpringWorks Therapeutics and Satsuma Pharmaceuticals on Thursday. Combined, the three companies raised more than $595 million from their IPOs.
According... Read more »
Even after three years, it doesn’t get any easier to choose the winners of the Xconomy Awards in Boston. There were multiple deserving winners in each category this year. But after much discussion and debate among our judges and... Read more »
Tocagen’s experimental gene therapy for brain cancer therapy has failed a late-stage test, sinking the biotech’s stock price below $1.
San Diego’s Tocagen (NASDAQ: TOCA), has been testing its drug in recurrent high-grade glioma, the most common and deadly type... Read more »
The consumerization of healthcare is accelerating. Within five years, a “significant percentage” of healthcare services will be run through mobile apps and other digital tools, predicts John Halamka, a Boston-based doctor and prominent digital health expert.
Halamka shared his prognostication in... Read more »
[Updated 9/12/19 1:10 p.m. See below.] Swiftly, a Seattle-based startup developing software to provide discounts and rewards for buying goods at grocery stores, exited stealth mode this week with an announcement it has raised more than $15 million... Read more »
Peanut allergy sufferers know they need to stay away from certain foods that can put them in danger. But what about accidental exposure? Even trace amounts of peanut protein in their food or someone else’s can trigger an allergic reaction that... Read more »
GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures.
Avalon said Tuesday that GSK (NYSE: GSK) has agreed to buy the company, Sitari Pharmaceuticals, which has... Read more »
Phil Sharp is one of the godfathers of biotech. He’s an MIT biologist, Nobel laureate and, as a Biogen (NASDAQ: BIIB) co-founder, one of the people responsible for turning Kendall Square into the biopharma epicenter it is today.
Next month,... Read more »